Biotechnology

One in Six Globally Concerned About Colorectal Cancer Screening Costs

SHENZHEN, China, May 31, 2024 /PRNewswire/ -- By 2040, the burden of colorectal cancer (CRC) is projected to increase to 3.2 million new cases and 1.6 million deaths per year representing a 66% and 71% rise in new cases and deaths respectively relative to2020

2024-05-31 08:00 2587

Telix Announces Positive rPFS Data from ProstACT SELECT Trial of TLX591 rADC Therapy Candidate in Prostate Cancer

* TLX591 is an investigational anti-PSMA[1] radio-antibody-drug conjugate (rADC) therapy being developed for the treatment of mCRPC, differentiated by a short two-week dosing regimen. * Reported median radiographic progression-free survival (rPFS) is 8.8 months. * Builds on prior data from th...

2024-05-31 07:19 2010

LumaCina announces availability of Oral Morphine pain medication for New Zealanders

PERTH, Australia and MIAMI, May 31, 2024 /PRNewswire/ -- LumaCina, the pharmaceutical supplier and marketing division ofBridgewest Perth Pharma announce new production of Oral Morphine to meet critical drug shortage inNew Zealand. The shortfall of Oral Morphine has become increasingly concerning...

2024-05-31 05:17 1877

Metabolon Announces 4-Week Turnaround Time for Commercial Projects, Enhancing Metabolomic Services for Multiomic Research

MORRISVILLE, N.C., May 30, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced a significant enhancement to its serv...

2024-05-30 20:57 1339

Soterios Pharma Announces Positive Topline Results from Phase II Study of STS-01 in the Treatment of Mild / Moderate Alopecia Areata

* Once-daily topical treatment of mild / moderate alopecia areata (AA) with 1% STS-01 met the primary efficacy endpoint of >30% Severity of Alopecia Tool (SALT) score improvement compared to patients receiving placebo (p<0.0096) * Multiple secondary endpoints met with significant total hair re...

2024-05-30 07:05 3350

SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities

In collaboration with Microsoft and NVIDIA, SOPHiA GENETICS is developing a comprehensive whole genome analytical solution BOSTON and ROLLE, Switzerland, May 29, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven m...

2024-05-29 22:00 1603

Veritas Genetics at the forefront of genomic screening with new studies presented at the European Society of Human Genetics Conference - ESHG 2024

* Veritas will present two pioneering studies at the European Society of Human Genetics Conference, inBerlin from June 1 to June 4. With a focus on elective genomic screening and newborn genomic screening, Veritas aims to set new standards in preventive medicine. * The Conference, now in its...

2024-05-29 17:55 1881

Onconic Therapeutics Announces Positive Phase 3 Results for JAQBO at Digestive Diseases Week 2024

SEOUL, South Korea and WASHINGTON, May 29, 2024 /PRNewswire/ -- Onconic Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for oncology and gastrointestinal disorders, announced today the results of its Phase 3 ZERO-1 study of JAQBO (zastaprazan...

2024-05-29 17:35 2217

Frost & Sullivan Reported The Fourth Revolutionary Wave of Biologics Manufacturing: CDMOs Empower Large-scale Production of Biologics

SHANGHAI, May 29, 2024 /PRNewswire/ -- Recently, Frost & Sullivan released the report "The Fourth Revolutionary Wave of Biologics Manufacturing: CDMOs Empower Large-scale Production of Biologics".  I.  CDMOs are advancing the biopharmaceutical industry with superior biomanufacturing capabilities...

2024-05-29 14:08 1763

Spectacular advances creating a revolution in the diagnosis and treatment of male infertility

MANILA, Philippines, May 29, 2024 /PRNewswire/ -- Spectacular advances in the diagnosis and treatment of male infertility are offering new hope to the one in six couples globally who seek assisted reproduction to achieve their dreams of parenthood. A major conference on human reproduction in t...

2024-05-29 12:42 1565

US-Based Neurobiotic Leader Bened Life Launches Global Expansion with Neuralli™ MP

FREMONT, Calif., May 29, 2024 /PRNewswire/ -- Bened Life , the leader in psychobiotics, has begun worldwide expansion after finding success inthe United States with Neuralli™ MP - the first gut-brain medical probiotic for neurological conditions. Bened life is now spreadi...

2024-05-29 10:00 1825

US-Based Neurobiotic Leader Bened Life enters Japan market with Neuralli™ MP

FREMONT, Calif., May 29, 2024 /PRNewswire/ -- Bened Life , the leader in psychobiotics, has begun worldwide expansion after finding success inthe United States with Neuralli™ MP - the first gut-brain medical probiotic for neurological conditions. With investment from Teij...

2024-05-29 10:00 2445

TREEFROG THERAPEUTICS PICKS-UP BEST POSTER AWARD AT THE INTERNATIONAL SOCIETY FOR CELL & GENE THERAPY (ISCT) ANNUAL MEETING FOR THEIR CELL THERAPY PROGRAM IN PARKINSON'S DISEASE

-  Treefrog will present two posters on their cell therapy program in Parkinson's Disease and their proprietary encapsulation technology, C-Stem™ -   BORDEAUX, France, May 29, 2024 /PRNewswire/ -- TreeFrog Therapeutics  has a busy schedule at the ISCT's 30th annual meeti...

2024-05-29 06:00 1473

Metabolon Now Includes Spectral Data Files for All Global Discovery Panel Projects

MORRISVILLE, N.C., May 28, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced the availability of spectral data fil...

2024-05-28 21:00 1375

Turn Biotechnologies Signs Global Licensing Agreement with HanAll Biopharma to Develop Eye and Ear Therapies

* Synergistic collaboration to revolutionize age-related therapies worldwide * Deal valued at over $300 million USD for initial product MOUNTAIN VIEW, Calif., May 28, 2024 /PRNewswire/ -- Turn Biotechnologies, a developer of novel mRNA medicines and enabling technologies, today announced an e...

2024-05-28 19:00 1336

Stavian Chemical Ranks 17th in ICIS Top 100, Signaling Strong Growth Amid Global Market Challenges

HANOI, Vietnam, May 28, 2024 /PRNewswire/ -- Stavian Chemical, a leading global chemical distributor headquartered inVietnam, proudly announces its exceptional performance in the prestigiousICIS Top 100 Chemical Distributors for 2024. Demonstrating the company's robust growth and resilience in th...

2024-05-28 10:00 2520

Innovent Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to Submit NDA to the NMPA

SAN FRANCISCO and SUZHOU, China, May 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...

2024-05-28 08:00 2567

Telix Submits NDA for New Prostate Cancer Imaging Agent

MELBOURNE, Australia, May 27, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has submitted a New Drug Application (NDA) tothe United States (U.S.) Food and Drug Administration (FDA) for TLX007-CDx, a new and proprietary cold kit ("Kit") for th...

2024-05-27 07:21 1907

Critical need for doctors to counsel couples on potential genetic burden in offspring of older dads

MANILA, Philippines, May 26, 2024 /PRNewswire/ -- An increasing trend of older fatherhood is potentially creating a global genetic disaster with devastating health consequences for offspring. A major conference of human reproductive health in the Philippines will hear of mounting evidence that...

2024-05-26 15:59 2661

YS Biopharma Announces Name Change to LakeShore Biopharma

GAITHERSBURG, Md., May 24, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseas...

2024-05-24 19:30 2004
1 ... 13141516171819 ... 177